{"id":"https://openalex.org/W2890180098","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.8043","title":"Real-world evidence of cardiac hospitalizations in carfilzomib- and non-carfilzomib-treated multiple myeloma patients in the United States.","display_name":"Real-world evidence of cardiac hospitalizations in carfilzomib- and non-carfilzomib-treated multiple myeloma patients in the United States.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2890180098","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.8043","mag":"2890180098"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.8043","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.8043","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.8043","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058598134","display_name":"Joseph R Mikhael","orcid":"https://orcid.org/0000-0001-9670-2864","observed_orcids":["https://orcid.org/0000-0001-9670-2864"]},"institutions":[{"id":"https://openalex.org/I4210158220","display_name":"International Myeloma Foundation","ror":"https://ror.org/05qmfyw56","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210158220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Mikhael","raw_affiliation_strings":["International Myeloma Foundation, North Hollywood, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Myeloma Foundation, North Hollywood, CA;","institution_ids":["https://openalex.org/I4210158220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012989885","display_name":"Khalid Mezzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khalid Mezzi","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112272601","display_name":"Karim Saad Iskander","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karim Iskander","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kenneth Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Wang","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104667865","display_name":"Christopher Kim","orcid":"https://orcid.org/0000-0002-0257-8696","observed_orcids":["https://orcid.org/0000-0002-0257-8696"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Kim","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109972084","display_name":"Shao Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shao Zhu","raw_affiliation_strings":["Amgen, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022899760","display_name":"Megan Braunlin","orcid":"https://orcid.org/0000-0002-1730-9691","observed_orcids":["https://orcid.org/0000-0002-1730-9691"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan Braunlin","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086135145","display_name":"Winifred Werther","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Winifred A. Werther","raw_affiliation_strings":["Amgen, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006108161","display_name":"Ajai Chari","orcid":"https://orcid.org/0000-0002-0405-7480","observed_orcids":["https://orcid.org/0000-0002-0405-7480"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajai Chari","raw_affiliation_strings":["Mount Sinai School of Medicine, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai School of Medicine, New York, NY;","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"8043","last_page":"8043"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11638","display_name":"Cardiac tumors and thrombi","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.9779999852180481},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cardiac-hospitalization","display_name":"cardiac hospitalization","score":0.9259999990463257},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7630000114440918},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8980000019073486},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cardiac-arrhythmia","display_name":"cardiac arrhythmias","score":0.7459999918937683},{"id":"https://openalex.org/keywords/cardiomyopathy","display_name":"cardiomyopathy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/ischemic-heart-disease","display_name":"ischemic heart disease","score":0.8560000061988831},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6570000052452087},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5960000157356262},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.5630000233650208},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4740000069141388},{"id":"https://openalex.org/keywords/american-patients","display_name":"United States patients","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9452725648880005},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.9423554539680481},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6163771748542786},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5773152709007263},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5097024440765381},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.487030565738678},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.47393327951431274},{"id":"https://openalex.org/C2778797674","wikidata":"https://www.wikidata.org/wiki/Q847583","display_name":"Cardiomyopathy","level":3,"score":0.4662306308746338},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.4385315775871277},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4295123219490051},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.37305641174316406},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.20098480582237244},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.8043","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.8043","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.8043","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7799999713897705}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2526451291","https://openalex.org/W2912170340","https://openalex.org/W4318915818","https://openalex.org/W2981119906","https://openalex.org/W2145932487","https://openalex.org/W1482919481","https://openalex.org/W2890180098","https://openalex.org/W2063424779","https://openalex.org/W2887253292","https://openalex.org/W3214088986"],"abstract_inverted_index":{"8043":[0],"Background:":[1],"Approximately":[2],"30%":[3],"of":[4,41,72,238,252,280,308,333],"multiple":[5],"myeloma":[6],"(MM)":[7],"patients":[8],"(pts)":[9],"are":[10],"hospitalized":[11],"for":[12,170,231,261,274,299,340,349],"cardiac":[13,120,127,133,154,217],"events":[14],"after":[15],"MM":[16,29,42,69],"diagnosis.":[17,70,158],"Carfilzomib":[18],"(K),":[19],"a":[20,35,132,153],"2nd":[21],"generation":[22],"proteasome":[23],"inhibitor,":[24],"was":[25,85,212,226,269,288,338],"approved":[26],"to":[27,99],"treat":[28],"in":[30,114,204,215,240,248,263,282,304],"2012.":[31],"Methods:":[32],"We":[33],"conducted":[34],"matched":[36,97,343],"retrospective":[37],"claims-based":[38],"cohort":[39,242],"study":[40],"pts":[43,101,182,239,265,268,284,287,346],"who":[44,92],"initiated":[45],"K":[46,100,178,264,283,309],"or":[47],"non-K":[48,94,181,234,255,267,286,311,344],"treatment":[49],"(tmt)":[50],"between":[51],"2012-2015":[52],"using":[53,79,111],"Truven":[54],"MarketScan.":[55],"Pts":[56,91],"were":[57,77,96,109,167,183,196,202,243,294],">":[58],"18":[59],"yrs":[60],"and":[61,75,105,125,162,173,179,188,200,208,220,228,233,250,254,306,310,342,352],"had":[62,152],"\u22651":[63],"yr":[64],"baseline":[65],"(BL)":[66],"data":[67],"before":[68],"Line":[71],"therapy":[73],"(LOT)":[74],"regimens":[76,95],"identified":[78,110,184],"drug":[80],"prescription":[81],"claims.":[82],"Index":[83],"LOT":[84,205],"defined":[86,129],"as":[87,130,143,156],"first":[88],"K-containing":[89],"LOT.":[90,107,118],"received":[93],"2:1":[98],"on":[102,146],"age,":[103],"sex,":[104],"index":[106,117],"Hospitalizations":[108],"diagnosis":[112],"codes":[113],"claims":[115],"during":[116,336],"Any":[119,245],"hospitalizations":[121,335],"(CH)":[122],"included":[123],"new":[124],"existing":[126],"conditions":[128],"having":[131],"code":[134,155],"(arrhythmia,":[135],"heart":[136,139],"failure,":[137],"ischemic":[138],"disease,":[140],"cardiomyopathy,":[141],"hypertension)":[142],"primary/secondary":[144],"diagnoses":[145],"the":[147,331,359],"claim;":[148],"primary":[149,157],"CH":[150,246,262,281],"(PCH)":[151],"Odds":[159],"ratios":[160],"(OR)":[161],"95%":[163],"confidence":[164],"intervals":[165],"(CI)":[166],"calculated,":[168],"adjusting":[169,298],"tmt":[171,224,275,337,350],"duration":[172,225,351],"BL":[174,216,300,353],"conditions.":[175,301,354],"Results:":[176],"498":[177],"996":[180],"(median":[185],"age":[186],"61":[187],"62":[189],"yrs,":[190],"respectively).":[191,222],"In":[192,327],"both":[193],"cohorts,":[194],"59%":[195],"male;":[197],"6%,":[198],"30%,":[199],"64%":[201],"treated":[203,345],"1,":[206],"2,":[207],"3+.":[209],"Overall,":[210],"there":[211],"no":[213],"difference":[214],"history":[218],"(84.9%":[219],"84.1%,":[221],"Median":[223],"105":[227],"158":[229],"days":[230],"K-":[232,253,341],"pts,":[235,312,330],"respectively.":[236],"34%":[237],"each":[241],"hospitalized.":[244],"occurred":[247,303],"16%":[249],"12%":[251],"pts.":[256],"Unadjusted":[257],"OR":[258,277,315,321],"(95%":[259,278],"CI)":[260,279],"vs":[266,285],"1.47":[270],"(1.1\u20132.0).":[271],"When":[272],"adjusted":[273,320,348],"duration,":[276],"1.1":[289],"(0.8\u20131.5).":[290],"Similar":[291],"hospitalization":[292],"risks":[293],"seen":[295],"when":[296,347],"additionally":[297],"PCH":[302],"2%":[305],"3%":[307],"respectively":[313],"(unadjusted":[314],"[95%":[316,322],"CI]":[317,323],"0.7":[318],"[0.4\u20131.4];":[319],"0.55":[324],"[0.3\u20131.1]).":[325],"Conclusions:":[326],"real":[328],"world":[329],"risk":[332,360],"cardiac-related":[334],"similar":[339],"Selection":[355],"bias":[356],"may":[357],"impact":[358],"estimates.":[361]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}